Advertisement
Advertisement
NBTX
Nanobiotix S.A. - ADR
34.82
USDSponsored
-0.33
-0.95%
Sep 23, 11:53 UTC -4
Open
NBTX Earnings Reports
Positive Surprise Ratio
NBTX beat 4 of 16 last estimates.
25%
Next Report
Next Week
Date of Next Report
Sep 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$30.50M
/-$0.11
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+14.49%
/--
Nanobiotix S.A. - ADR earnings per share and revenue
On --, NBTX reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 30.50 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AnaptysBio, Inc. Common Stock
Report Date
Sep 21, 2026 For Q2 26
Estimate
$0.00
Actual
$5.11
Surprise
>+10,000.00%
BlossomHill Therapeutics, Inc. Common Stock
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$1.03
Actual
-$8.75
Surprise
-746.56%
Vogenx Inc Common Stock
Report Date
Sep 17, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+1.96%
Benitec Biopharma Inc. Common Stock
Report Date
Sep 14, 2026 For Q4 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+5.59%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Abivax SA - ADR
Report Date
Sep 21, 2026 For Q2 26
Estimate
-$1.82
Actual
-$2.09
Surprise
-14.47%
AYTU BioPharma, Inc. Common Stock
Report Date
Sep 22, 2026 For Q4 26
Estimate
-$0.33
Actual
-$0.05
Surprise
+84.92%
Neuphoria Therapeutics Inc. Common Stock
Report Date
Sep 18, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.95
Surprise
-66.32%
NewcelX Ltd. Ordinary Shares
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$0.54
Actual
-$0.96
Surprise
-77.58%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Nanobiotix S.A. - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Nanobiotix S.A. - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Nanobiotix S.A. - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Nanobiotix S.A. - ADR expected to report next?
The next earning report is scheduled for Sep 28, 2026.
What are the forecasts for Nanobiotix S.A. - ADR's next earnings report?
Based on 3
analysts, Nanobiotix S.A. - ADR is expected to report EPS of -$0.11 and revenue of $30.50M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.